Sponsor Pipeline

TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
5
Disease Areas
Active Trials by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06343402 Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer Non-small Cell Lung Cancer Recruiting
NCT06917079 BBO-11818 in Adult Subjects With KRAS Mutant Cancer Non-Small Cell Lung Cancer Recruiting
NCT06625775 Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors Solid Tumor, Adult Recruiting
Disease Areas
Lung Cancer (3) Non-Small Cell Lung Cancer (NSCLC) (2) Colorectal Cancer (2) Breast Cancer (1) Pancreatic Cancer (1)
Get alerts when TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free